CLAIM CARD
Additional corpus sources included animal/preclinical evidence; additional corpus sources informed the synthesis without anchoring a foregrounded quantitative claim and are catalogued for completeness: Lee 2014, Wang 2026, Delic 2018, Perez-Martinez 2024, Zurlo 2023, Gao 2018, Sasaki 2020, Bindels 2023, Comi 2025, Nie 2021, Mercer 2016, Koga 2025, Roark 2025, Ortega-Matienzo 2025, Dai 2014, Tao 2005, Rapamycin 2017, Kraig 2018, Chakraborty 2023, Abstract 2025, Everolimus 2026, Aliper 2017, Leontieva 2017, Sabini 2023, Zaseck 2016, Svensson 2024b, Flynn 2013, Majumder 2012, Wilkinson 2012, Mtor 2026, Cognition 2022, Rapamycin 2026, Sirolimus 2013, Ataman 2024, Arasiewicz 2026.
Evidence grade: exploratory
Contradiction status: none
Publication: f02d4a53-03e5-47ed-9876-75a416e3bd24
Provenance: Derivation Web chain
Citation Support
source_1Moel 2025source_2Gkioni 2025source_3Smiaek 2023source_4Willows 2023source_5Harinath 2025